SYSTEMATIC REVIEW
Accepted on 25 Nov 2025
Efficacy of TACE plus tyrosine kinase inhibitors and immune checkpoint inhibitors in the treatment of patients with unresectable hepatocellular carcinoma: A systematic review and Meta-analysis
- 141 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Immuno-metabolic Approaches for the Treatment of Hepatobiliary and Pancreatic Tumors
Immuno-metabolic Approaches for the Treatment of Hepatobiliary and Pancreatic Tumors
4,864
Total downloads
25k
Total views and downloads
Articles
REVIEW
Published on 18 Nov 2025
Reprogramming the tumor microenvironment to overcome immunotherapy resistance in pancreatic cancer
doi 10.3389/fimmu.2025.1717062
- 1,258 views
CASE REPORT
Published on 10 Nov 2025
Pembrolizumab combined with surgical treatment for spontaneously ruptured undifferentiated pleomorphic sarcoma of the liver: a case report and literature review
doi 10.3389/fimmu.2025.1691575
- 692 views
ORIGINAL RESEARCH
Published on 22 Oct 2025
Prognostic analysis of different postoperative adjuvant therapies for patients with hepatocellular carcinoma after radical resection with high-risk recurrence factors: a multicenter real-world retrospective study
doi 10.3389/fimmu.2025.1661923
- 1,153 views
ORIGINAL RESEARCH
Published on 22 Sep 2025
Development of a nomogram integrating immune checkpoints, fibrosis indicators, and clinicopathological characteristics to predict overall survival in pancreatic cancer: a retrospective analysis
doi 10.3389/fimmu.2025.1688440
- 1,244 views
ORIGINAL RESEARCH
Published on 12 Sep 2025
Hepatic arterial interventional therapies alone or in combination with molecular targeted therapies and PD-(L)1 inhibitors in locally aggressive, early recurrent hepatocellular carcinoma: a retrospective study
doi 10.3389/fimmu.2025.1643082
- 1,217 views
REVIEW
Published on 08 Aug 2025
Immunotherapy in biliary tract cancer: reshaping the tumour microenvironment and advancing precision combination strategies
doi 10.3389/fimmu.2025.1651769
- 3,249 views
- 1 citation
ORIGINAL RESEARCH
Published on 03 Jul 2025
Serum GDF15 level as predictive biomarker of clinical outcome in patients with unresectable hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy
doi 10.3389/fimmu.2025.1619387
- 1,706 views
- 1 citation
ORIGINAL RESEARCH
Published on 12 Jun 2025
PD-1 inhibitor-augmented HAIC-TKI therapy in hepatocellular carcinoma with portal vein tumor thrombosis: real-world survival benefits, safety, and subgroup-specific efficacy
doi 10.3389/fimmu.2025.1602031
- 2,788 views
- 2 citations
ORIGINAL RESEARCH
Published on 11 Jun 2025
Utilization of artificial circular RNAs as miRNA sponges and anti-PD-1 scFv expression platforms to suppress hepatocellular carcinoma progression
doi 10.3389/fimmu.2025.1609165
- 2,197 views
- 1 citation
ORIGINAL RESEARCH
Published on 14 Apr 2025
Heterogenous cancer-associated fibroblasts related tumor microenvironment marked by CD10/KLF4/TIAM1 were identified in pancreatic adenocarcinoma by integrated transcriptomics
doi 10.3389/fimmu.2025.1557698
- 4,465 views
- 4 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Other participating journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore